GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Clinical trials for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tracking a targeted radiation drug for Hard-to-Treat gut cancers
Disease control OngoingThis study is observing how well a treatment called Lutathera works for adults with advanced, progressing neuroendocrine tumors in the gut or pancreas. Lutathera is a targeted radiation drug already used in standard care. Researchers will follow 164 patients for up to 3 years to …
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 15, 2026 16:15 UTC
-
Massive study aims to uncover best treatments for rare tumors
Knowledge-focused OngoingThis study follows over 2,500 people with neuroendocrine tumors (NETs) to learn how symptoms and treatments affect their quality of life. Participants fill out surveys about their well-being and care experiences for up to 18 months. The goal is to find which treatments work best …
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Sponsor: University of Iowa • Aim: Knowledge-focused
Last updated May 08, 2026 12:01 UTC